Association between sex steroid hormones and subsequent hyperglycemia during pregnancy

• Published in: Frontiers in endocrinology (Lausanne) Vol. 14; p. 1213402
• Main Authors: Meng, Ying, Thornburg, Loralei L., Hoeger, Kathleen M., Núñez, Zorimar Rivera, Kautz, Amber, Evans, Adam T., Wang, Christina, Miller, Richard K., Groth, Susan W., O’Connor, Thomas G., Barrett, Emily S.
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 08.09.2023
• Subjects: Cohort Studies; Diabetes, Gestational; Endocrinology; estrogen; Estrone; Female; gestational diabetes; Glucose; Gonadal Steroid Hormones; Humans; Hyperglycemia; Pregnancy; Prospective Studies; Retrospective Studies; sex steroid hormone; Testosterone; sex steroid hormone; hyperglycemia; estrogen; testosterone; gestational diabetes
• ISSN: 1664-2392; 1664-2392
• DOI: 10.3389/fendo.2023.1213402

Sex steroid hormones may play a role in insulin resistance and glucose dysregulation. However, evidence regarding associations between early-pregnancy sex steroid hormones and hyperglycemia during pregnancy is limited. The primary objective of this study was to assess the relationships between first trimester sex steroid hormones and the subsequent development of hyperglycemia during pregnancy; with secondary evaluation of sex steroid hormones levels in mid-late pregnancy, concurrent with and subsequent to diagnosis of gestational diabetes. Retrospective analysis of a prospective pregnancy cohort study was conducted. Medically low-risk participants with no known major endocrine disorders were recruited in the first trimester of pregnancy (n=319). Sex steroid hormones in each trimester, including total testosterone, free testosterone, estrone, estradiol, and estriol, were assessed using high-performance liquid chromatography and tandem mass spectrometry. Glucose levels of the 1-hour oral glucose tolerance test and gestational diabetes diagnosis were abstracted from medical records. Multivariable linear regression models were fitted to assess the associations of individual first trimester sex steroids and glucose levels. In adjusted models, first trimester total testosterone (β=5.24, 95% CI: 0.01, 10.46, p=0.05) and free testosterone (β=5.98, 95% CI: 0.97, 10.98, p=0.02) were positively associated with subsequent glucose concentrations and gestational diabetes diagnosis (total testosterone: OR=3.63, 95% CI: 1.50, 8.78; free testosterone: OR=3.69; 95% CI: 1.56, 8.73). First trimester estrone was also positively associated with gestational diabetes (OR=3.66, 95% CI: 1.56, 8.55). In mid-late pregnancy, pregnant people with gestational diabetes had lower total testosterone levels (β=-0.19, 95% CI: -0.36, -0.02) after adjustment for first trimester total testosterone. Early-pregnancy sex steroid hormones, including total testosterone, free testosterone, and estrone, were positively associated with glucose levels and gestational diabetes in mid-late pregnancy. These hormones may serve as early predictors of gestational diabetes in combination with other risk factors.